Successful Formation of a Chimeric Human Thymus Allograft Following Transplantation of Cultured Postnatal Human Thymus

Journal of Immunology

Volumn 158, Issue 2, 1997, Pages 998-1005

  Markert, M Louise ^a,b   Kostyu, Donna D ^b   Ward, Frances E ^b   McLaughlin, Tanya M ^a   Watson, T J ^a   Buckley, Rebecca H ^a,b   Schiff, Sherrie E ^a   Ungerleider, Ross M ^b   Gaynor, J William ^b   Oldham, Keith T ^b   Mahaffey, Samuel M ^b   Ballow, Mark ^c   Driscoll, Deborah A ^d   Hale, Laura P ^b   Haynes, Barton F ^a,b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY   (United States)

^c UNIVERSITY AT BUFFALO   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOTRANSPLANTATION; ARTICLE; CHIMERA; DIGEORGE SYNDROME; GRAFT SURVIVAL; HUMAN; IMMUNOLOGY; INFANT; ORGAN CULTURE TECHNIQUE; PATHOLOGY; THYMUS; TRANSPLANTATION;

CHIMERA; DIGEORGE SYNDROME; GRAFT SURVIVAL; HUMANS; INFANT; ORGAN CULTURE TECHNIQUES; THYMUS GLAND; TRANSPLANTATION, HOMOLOGOUS;

EID: 0031568004     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. DiGeorge, A. M. 1965. Discussion of Cooper MD, Peterson RDA, Good RA. J. Pediatr. 67:907 (Abst).
2. Conley, M. E., J. B. Beckwith. J. F. K. Mancer, and L. Tenckhoff. 1979. The spectrum of the DiGeorge syndrome. J. Pediatr. 94:883.
3. Hong, R. 1991. The DiGeorge anomaly, Immunodef. Rev. 3:1.
4. + T-lymphocyte regeneration after intensive chemotherapy. N. Eng. J. Med. 332:143.
5. August, C. S., F. S. Rosen, R. M. Filler, C. A. Janeway, B. Markowski. and H. E. M. Kay. 1968. Implantation of a fetal thymus restoring immunological competence in a patient with thymic aplasia (DiGeorge's syndrome). Lancet 2:1210.
6. August, C. S., A. I. Berkel, R. H. Levey, and R. S. Rosen. 1970. Establishment of immunological competence in a child with congenital thymic aplasia by a graft of fetal thymus. Lancet 1:2080.
7. Cleveland, W. W., B. J. Fogel, W. T. Brown, and H. E. M. Kay. 1968. Fetal thymic transplant in a case of DiGeorge syndrome. Lancet 2:1211.
8. Jose, D. G., G. Barnes. E. J. R. Rossiter, N. A. Myers, and M. G, Fitzgerald. 1974. Reconstitution of cellular immune function in a child with thymic aplasia by foetal thymus grafting. Aust. N. Z. J. Med. 4:267.
9. Mayumi, M., H. Kimata, Y. Suehiro, S. Hosoi, S. Ito, Y. Kuge, K. Shinomiza, and H. Mikawa. 1989. DiGeorge syndrome with hypogammaglobulinaemia: a patient with excess suppressor T-cell activity treated with fetal thymus transplantation. Eur. J. Pediatr. 148:518.
10. Touranine, J. L. 1979. Human T-lymphocyte differentiation in immunodeficiency diseases and after reconstitution by bone marrow or fetal thymus transplantation. Clin. Immunol. Immurwpath. 12:228.
11. Thong, Y. H., E. F. Robertson, H. G. Rischbieth, G. J. Smith, G. F. Binns, K. Chetney, and A. C. Pollard. 1978. Successful restoration of immunity in the DiGeorge syndrome with fetal thymic epithelial transplant. Arch. Dis. Child. 53:580.
12. Bastian, J., S. Law, L. Vogler, A. Lawton, H. Herrod, S. Anderson, S. Horowitz, and R. Hong, 1989. Prediction of persistent immunodeficiency in the DiGeorge anomaly. J. Pediatr. 115:391.
13. Hong, R. 1986. Reconstitution of T-cell deficiency by thymic hormone or thymus transplantation therapy. Clin, Immunol. Immunopath. 40:136.
14. Jenkinson, E. J., L. L. Franchi, R. Kingston, and J. J. T. Owen. 1982. Effect of deoxyguanosine on lymphopoiesis in the developing thymus rudiment in vitro: application in the production of chimeric thymus rudiments. Eur. J. Immunol. 12:583.
15. Buckley, R. H., S. E. Schiff, H. A. Sampson, R. I. Schiff, M. L. Marken, A. P. Knutsen, M. S. Hershfield, A. T. Huang, G. H. Mickey, and F. E. Ward. 1986. Development of immunity in severe primary T cell deficiency following haploidentical bone marrow stem cell transplantation. J. Immunol. 136:2398.
16. Amos, D. B., P. Pool, and J. Grier. 1980. HLA-A, HLA-B, HLA-C and HLA-DR. In Manual of Clinical Immunolog, N. R. Rose, and H. Friedman, eds. American Society for Microbiology, Washington D.C., p. 978.
17. Kostyu, D. D., J. Pfohl, F. E. Ward, J. Lee, A. Marray, and D. B. Amos. 1993. Rapid HLA-DR oligotyping by an enzyme-linked immunosorbent assay performed in microtiter trays. Hum. Immunol. 38:148.
18. Sedgwick, A. K., K. Sparks, and R. C. Tilton. 1983. Rapid quantitative microenzyme-linked immunosorbent assay for tetanus antibodies. J. Clin. Microbiol. 18: 104.
19. Gray, B. M., D. G. Pritchard, J. D. Springfield, R. J. Benak, and H. C. Dillon. 1988. Seroepidemiology of group B Streptococcus type II antibody specificity. Epidemiol. Infect. 101:347.
20. Koskela, M. 1987. Serum antibodies to pneumococcal C polysaccharide in children: response to acute pneumococcal otitis media or to vaccination. Pediatr. Infect. Dis. J. 6:519.
21. Messina, J. P., P. G. Hickox. M. L. Lepow, B. Pollara, and R. A. Venezia. 1985. Modification of a direct enzyme-linked immunosorbent assay for the detection of immunoglobulin G and M antibodies to pneumococcal capsular polysaccharide. J. Clin. Microbiol. 21:390.
22. McFarland, E. J., R. M. Scearce, and B. F. Haynes. 1984. The human thymic microenvironment: cortical thymic epithelium is an antigenically distinct region of the thymic microenvironment. J. Immunol. 133:1241.
23. Haynes, B. F., K. Shimizu, and G. S. Eisenbarth. 1983. Identification of human and rodent thymic epithelium using tetanus toxin and monoclonal antibody A2B5. J. Clin. Invest. 71:9.
24. Palker, T. J., R. M. Scearce. W. Ho, T. D. Copeland, S. Oroszlan, M. Popovic, and B. F. Haynes. 1985. Monoclonal antibodies reactive with human T cell lymphotropic virus I (HTLVI) p19 internal core protein: cross-reactivity with normal tissues and differential reactivity with HTLV types I and II. J. Immunol. 135:247.
25. Lobach, D. F., and B. F. Haynes. 1987. Ontogeny of the human thymus during fetal development J. Clin. Immunol. 7:1.
26. Eichner, R., P. Bonitz, and T. T. Sun. 1984. Classification of epidermal keratins according to their immunoreactivity. isoelectric point, and mode of expression. J. Cell. Biol. 98:1388.
27. Erkeller-Yuksel, F. M., V. Deneys, B. Yuksel, I. Hannet, F. Hulstaert, C. Hamilton, H. Mackinnon, L. T. Stokes, V. Munhyeshuli, F. Vanlangendonck, M. De Bruyère, B. A. Bach, and P. M. Lydyard. 1992. Age-related changes in human blood lymphocyte subpopulations. J. Pediatr. 120:216.
28. Driscoll, D. A., J. Salvin, B. Sellinger, M. L. Budarf, D. M. McDonald-McGinn, E. H. Zackai, and B. S. Emanuel. 1993. Prevalence of 22ql 1 microdeletions in DiGeorge and velocardiofacial syndromes: implications for genetic counseling and prenatal diagnosis. J. Med. Genet. 30:813.
29. Herod, H. G., R. J. Cooke, W. R. Valenski, J. Herman, and M. E. Dockter. 1991. Evaluation of lymphocyte phenotype and phytohemagglutinin response in healthy very low birth weight infants. Clin. Immunol. Immunopath. 60:268.
30. Marsh, S. G. E., and J. G. Bodmer. 1992. HLA class II nucleotide sequences, 1992. Hum. Immunol. 35:1.
31. Wara. D. W., M. S. Golbus, and A. J. Amman. 1974. Fetal thymus glands obtained from prostaglandin-induced abortions. Transplantation 18:387.
32. Markert, M. L., T. J. Watson, I. Kaplan, L. P. Hale, and B. F. Haynes. 1997. The human thymic microenvironment during organ culture. Clin. Immunol. Imunopath. 82:26.
33. Kay, H. E., and J. F. Soothill. 1969. Transplanting the thymus. Lancet 1:571.
34. Daga, S. R., M. P. Lokhande, P. G. Prabhu, H. M. Siddiqui, L. Chandrashekhar, and B. N. Kansaria. 1984. Immuno-reconstitution by thymic transplant in DiGeorge's syndrome. Postgrad. Med. J. 60:537.
35. - T cells. J Immunol. 140:3727.
36. - T cells produce IL-2 but fail to proliferate in response to mitogenic stimuli. J. Immunol. 141: 3691.
37. Wara, D. W., and A. J. Ammann. 1978. Thymosin treatment of children with primary immunodeficiency disease. Transplantation Proceedings 10:203.
38. Archer, E., T. Y. Chuang, and R. Hong. 1990. Severe eczema in a patient with DiGeorge's syndrome. Cutis 45:455.
39. Barrett, D. J., D. W. Wara, A. J. Ammann, and M. J. Cowan. 1980. Thymosin therapy in the DiGeorge syndrome. J. Pediatr. 97:66.
40. Aiuti, F., M. Fiorilli, I. Quinti, R. Seminara, L. Businco, E. Galli, P. Rossi, and G. Goldstein. 1983. Thymopoietin pentapeptide treatment of primary immuno-deficiencies. Lancet 1:551.
41. Pilarski, L. M., and J. P. Deans. 1993. CD45 isoform transitions on multinegative human thymocytes differentiating in vitro mimic patterns predicted for selective events in vivo. Immunol. Cell. Biol. 71:289.
42. Mackall, C. L., L. Granger, M. A. Sheard, R. Cepeda, and R. E. Gress. 1993. T cell regeneration after bone marrow transplantation: differential CD45 isoform expression on thymic-derived versus thymic-independent progeny. Blood 82:2585.
43. Zinkernagel, R. M., A. Althage, E. Watefield. B. Kindred. R. M. Welsh, G. Callahan, and P. Pincet. 1980. Restriction specificities, alloreactivity, and allotolerance expressed by T cells from nude mice reconstituted with H-2-compatible or -incompatible thymus grafts. J. Exp. Med. 151:376.
44. Lake, J. P., M. E. Andrew, C. W. Pierce, and T. J. Barciale. 1980. Sendai virusspecific, H-2 restricted cytotoxic T lymphocyte responses of nude mice grafted with allogeneic or sémi-allogeneic thymus glands. J. Exp. Med. 152:1805.
45. Kruisbeek, A. M., S. O. Sharrow, B. J. Mathieson, and A. Singer. 1991. The H-2 phenotype of the thymus dictates the self-specificity expressed by thymic but not splenic cytotoxic T lymphocyte precursors in thymus-engrafted nude mice. J. Immunol. 127:2168.
46. Kast, W. M., L. P. de Waal, and C. J. M. Melief. 1984. Thymus dictates major complex (MHC) specificity and immune response gene phenotype of class II MHC-restricted T cells but not of class I MHC-restricted T cells. J. Exp. Med. 160:1752.
47. Longo, D. L., A. M. Kruisbeek, M. L. Davis, and L. A. Matis. 1985. Bone marrow-derived thymic antigen-presenting cells determine self-recognition of Ia-restricted T lymphocytes. Proc. Natl. Acad. Sci. USA 82:5900.
48. Benoist, C., and D. Mathis. 1989. Positive selection of the T cell repertoire: where and when does it occur. Cell 58:1027.
49. Hong, R., H. Schulte-Wissermann, E. Jarrett-Toth, S. D. Horowitz, and D. D. Manning. 1979. Transplantation of cultured thymic fragments. II. Results in nude mice. J. Exp. Med. 149:398.
50. Marrack, P., J. McCormack, and J. Kappler. 1989. Presentation of antigen, foreign major histocompatibility complex proteins and self by thymus cortical epithelium. Nature 338:503.
51. Vukmanovic, S., A. G. Grandea, S. J. Faas, B. B. Knowles, and M. J. Bevan. 1992. Positive selection of T-lymphocytes induced by intrathymic injection of a thymic epithelial cell line. Nature 359:729.
52. Pawlowski, T., J. D. Elliott, D. Y. Loh, and U. D. Staerz. 1993. Positive selection of T lymphocytes on fibroblasts. Nature 364:642.
53. Bix, M., and D. Raulet. 1992. Inefficient positive selection of T cells directed by haematopoietic cells. Nature 359:330.
54. Marrack, P., D. Lo, R. Brinster, R. Palmiter, L. Burkly, R. H. Flavell, and J. Kappler. 1988. The effect of thymus environment on T cell development and tolerance. Cell 53:627.
55. Lorenz, R. G., and P. M. Allen. 1989. Thymic cortical epithelial cells can present self-antigens in vivo. Nature 337:560.
56. Matzinger, P., and S. Guerder. 1989. Does T-cell tolerance require a dedicated antigen-presenting cell? Nature 338:74.
57. Modigliani, Y., V. Thomas-Vaslin, A. Bandeira, M. Coltey, N. M. Le Douarin, A. Coutinho, and J. Salaün. 1995. Lymphocytes selected in allogeneic thymic epithelium mediate dominant tolerance toward tissue grafts of the thymic epithelium haplotype. Proc. Natl. Acad. Sci. USA 92:7555.